Imaging & Biomarker Correlates on Outcomes in a Phase II Trial of Neoadjuvant Gemcitabine/Nab-Paclitaxel and Hypofractionated Image-Guided Radiotherapy (HIGRT) in Potentially Resectable Pancreas Cancer
Kent, C.L., Marin, D., Niedzwiecki, D., Stephens, S.J., Duffy, E., Malicki, M., Abbruzzese, J., Uronis, H., Blobe, G., Blazer, D.G., Czito, B., Willett, C.G., Palta, M.Volume:
105
Language:
english
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2019.06.2014
Date:
September, 2019
File:
PDF, 269 KB
english, 2019